Search KIDS
ORTHOPEDIATRICS CORP
Nasdaq · CIK 1425450
Last close22.16
Daily change+0.47 (2.17%)
10 Years gain+18.19%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
KIDS · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
51.9Momentum
63.7Acceleration
60.0Confidence
91.0Annual Revenue11
Quarterly Revenue42
Annual CFO11
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth23.1 / 25
Quality13.7 / 25
Capital Efficiency5.1 / 20
Balance Sheet5.7 / 15
Shareholder Economics1.6 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 2.7371 percentage points.
ROIC expansionROIC improved by 0.9063 percentage points.
Key Metrics
Revenue Growth TTM23.34%OK
Revenue CAGR 3Y24.56%OK
Gross Margin73.37%OK
Operating Margin-12.88%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-6.4%OK
Incremental Operating Margin 3Y-9.01%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y3.52%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $236.35M | $172.66M | -$39.24M | -$4.85M | -$15.96M | 73.05% | -16.6% | -6.75% | -8.21% | 23.46M |
| 2025 FY Dec 31, 2024 | $204.73M | $148.60M | -$35.01M | -$27.05M | -$41.31M | 72.58% | -17.1% | -20.18% | -8.24% | 23.08M |
| 2025 FY Dec 31, 2023 | $148.73M | $111.25M | -$26.75M | -$27.05M | -$43.92M | 74.8% | -17.99% | -29.53% | -7.43% | 22.68M |
| 2024 FY Dec 31, 2022 | $122.29M | $90.66M | -$25.40M | -$21.77M | -$31.80M | 74.14% | -20.77% | -26% | -9.24% | 20.95M |
| 2023 FY Dec 31, 2021 | $98.05M | $73.40M | -$18.02M | -$13.06M | -$21.17M | 74.86% | -18.38% | -21.59% | -8.76% | 19.27M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $252.20M | sum latest 4 fiscal quarters Revenue | OK | 0001425450-26-000070, 0001425450-25-000114 |
| Revenue Growth TTM | 23.34% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001425450-26-000070, 0001425450-25-000114 |
| Revenue CAGR 3Y | 24.56% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001425450-26-000013 |
| Revenue CAGR 5Y | 27.16% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001425450-26-000013 |
| Gross Profit CAGR 3Y | 23.95% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001425450-26-000013 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001425450-26-000070, 0001425450-25-000114 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 73.37% | Gross Profit / Revenue | OK | 0001425450-26-000070, 0001425450-25-000114 |
| Operating Margin | -12.88% | Operating Income / Revenue | OK | 0001425450-26-000070, 0001425450-25-000114 |
| ROIC | -6.4% | NOPAT / Average Invested Capital | OK | 0001425450-26-000070, 0001425450-25-000114 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001425450-26-000070 |
| Current Ratio | 4.78x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.43x | (Cash + Short-term Investments) / Total Debt | OK | 0001425450-26-000070 |
| Revenue per Diluted Share | $10.49 | Revenue / Diluted Shares | OK | 0001425450-26-000070, 0001425450-25-000114 |